Varenicline for Smoking Cessation in Heavy Drinking Smokers
To find out more about our free research programs that can help you quit smoking call (203) 974-7588. Email: infocentury@yale.edu |
Yale researchers are investigating the use of the medication varenicline to help men and women who drink alcohol quit smoking.
Varenicline is a medication that targets nicotine receptors in the brain. It has been approved as a smoking cessation medication and is also being investigated for its potential effect on alcohol consumption.
“Alcohol use is a common relapse trigger for men and women who are trying to quit smoking” said Stephanie O'Malley, professor of psychiatry at Yale School of Medicine, director of the Substance Abuse Research Division, and principal investigator for the Yale Transdisciplinary Tobacco Use Research Center (TTURC). “The development of a treatment that will allow smokers to quit while reducing alcohol use could improve quit rates for more smokers,” she said.
She and her team are looking for men and women smokers who want to quit and who also drink alcohol regularly to participate in an 8-week study to see whether it has an effect on their ability to quit smoking and their drinking. All participants will receive counseling to help them quit smoking. Some of the participants will receive placebo varenicline for the first 3 weeks and some will receive varenicline. All of the participants will then receive varenicline for 5 weeks thereafter.
Yale TTURC is part of the Center for Nicotine and Tobacco Use Research at Yale and is one of seven research centers nationwide conducting a diverse spectrum of transdisciplinary tobacco-related research. It is funded by the National Cancer Institute, the National Institute on Alcohol Abuse and Alcoholism, and the National Institute on Drug Abuse.
(HIC # 0809004276)
Click here to watch our video advertisement
Smoking Cessation after Head and Neck Cancer Treatment
Are you a smoker being treated for head and neck cancer
at the Yale Cancer Center?
Do you want to quit?
We can help.
To be eligible, you must be a Yale Cancer Center patient who was treated for head and neck cancer. Our research program will provide you with FDA approved medication, counseling. and support. All treatment is provided at NO COST.
To learn more, speak with your Yale Cancer Center clinician.
(HIC #0903004910)
| 
